Large-scale testing (Phase 3)Ended earlyNCT00122551
What this trial is testing
Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)
Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 400